Haemopoietic growth factors stimulate a number of consensus biochemical and molecular events regardless of the specificity detailed by unique ligand and receptor structures. Analysis of three distinct colony stimulating factors, C SF s (IL-3, G -C SF, G M -CSF) and the lymphocytotropic growth factor IL-2 reveal remarkable similar distal subcellular biochemical signals although initial membrane 'signal transduction' may differ significantly. Both early progenitor cell growth factors, such as IL-3, and late acting factors such as CSF-1, stimulate tyrosine and serine-threonine substrate phosphorylations. One substrate (p68) is phosphorylated by many C S F stimulants, including IL-2, suggesting a highly conserved role in many unique receptor(s) signal transduction processes. The proliferative C SF s and IL-2 also stimulate the expression of many of the same genes including proto-oncogenes, ornithine decarboxylase and members of the ancient family of stress response genes. Although initial membrane events may differ among the respective proliferative stimulants, biochemical and molecular convergence on highly conserved cellular substrates and the programme of gene expression is seen.
Introduction
Proliferation of bone marrow haemopoietic precursors in vitro is dependent upon the presence of specific growth factors (reviewed by Dexter, 1984; Nicola & Vadas, 1984) . Several myeloid colony stimulating factors (C SF) have now been demon strated to possess unique primary amino acid sequences and distinct biological activities. In primary bone marrow cultures, G -C SF induces granulocyte colonies (Nicola et al. 1983 ); G M -CSF (Sparrow et al. 1985) induces mixed colonies of granulocytes and monocytes, whereas IL-3 (or multi C SF) (Ihle et al. 1982) stimulates the proliferation of a pluripotent stem cell population. Growth factordependent mouse myeloid cell lines, recently developed, provide valuable resources for studying the intracellular effects of the interaction between myeloid cells and C SFs.
Signal transduction is the biochemical process by which ligand-receptor interac tions simplify and amplify a series of chemical signals, which activate a myriad of enzymatic activities that regulate cell metabolism and macromolecular synthesis. A limited repertoire of signals generated at the membrane has been observed with a wide variety of hormones, neurotransmitters, or 'informational substances.' The number of second messengers is surprisingly small and remarkably universal. Two major signal pathways are now known. One employs cyclic adenosine monophos phate (cyclic AMP) and the other calcium ions and the phosphoinositide species, inositol triphosphate (IP3) and diacylglycerol. The paths have many common features. Both utilize specific protein recognition sites (receptors), which bind, with high affinity (K d = 10-9-1 0 -12m), informational substances which may have peptic or organic structures. In order for the signal to be initiated the informational substance (ligand) must bind the receptor outside the plasma membrane with sufficient affinity to engage the interaction of a GTP-binding protein with the receptor within the transmembrane structure.
The GTP-binding protein (G protein) is activated by binding guanosine triphosphate (G TP) and then 'tranduces' the external information to an amplifying system, adenylate cyclase (AC), for cyclic AMP coupled transduction and phospholi pase C (PL-C) for phosphoinositol coupled systems. The amplifier enzymes convert precursor molecules, usually with energy-rich phosphate groups, into second messengers. In the case of adenylate cyclase, ATP is converted into cyclic AMP, whereas PL-C hydrolyses phosphatidylinositol 4, S-bisphosphate (PIP2) into IP3 and diacylglycerol (D G ). IP3 stimulates the release of intracellular stores of Ca2+, effecting the activation of Ca2+-dependent kinases such as Ca2+-calmodulindependent protein kinase. Diacylglycerol stimulates the activation of a phospholipiddependent protein kinase, protein kinase C (PR-C). The result of the activation of these kinase systems is to regulate the function of specific substrate proteins. Both pathways can be mimicked by pharmacological analogues. Stable derivatives of cyclic AMP, can readily penetrate the cell and activate PK-A. Release of intracellular Ca2+ and Ca2+ influx can be irreversibly achieved by the addition of Ca2+ ionophores (ionomycin, A23187) to cell cultures. Likewise, a potent class of tumour promoters, phorbol esters, can penetrate the cell membrane and activate PK-C. These pharmacological stimulants have proven useful in cause-effect experimentation to elucidate the roles of the discrete second messengers in cellular functions and gene expression.
The mechanism(s) by which the external signal reaches the nucleus and results in specific gene transcription is unknown, but largely believed to involve protein phosphorylation. Although nuclear phosphoproteins for C SF or cytokine growth signals have not been investigated, we will discuss the available information regarding haemopoietic growth factor regulation of protein phosphorylation.
Mitogen stimulation of fibroblasts, lymphocytes and CSF-directed proliferation all result in the synthesis of consensus genes common to all cycling cells. Noteable are the proto-oncogenes, ornithine decarboxylase (ODC) and heat shock proteins (Harel-Bellan & Farrar, 1987; Farrar et al. 1988a; Ferris et al. unpublished; Cleveland et al. 1987; Ferris et al. 1988 ). Many of these gene products can also be stimulated or repressed by pharmacological activitors of PK-C or PK-A. Conversely, anti-proliferative signals such as cyclic AMP or interferons can be shown to repress growth response genes such as c-myc or ODC (Farrar et al. 19886; Harel-Bellan & Farrar, 1988; Farrar et al. 1987 ).
Here, we will present data summarizing some of the conserved biochemical events which are apparently involved in C S F mediated cellular proliferation and how these molecular targets may also be affected by anti-proliferative signals.
Results and discussion

C S F regulation of protein phosphorylation
While the importance of protein phosphorylation in regulating cellular metabolism has been well established, its precise role in growth factor-induced signal transduc tion is unclear.
Using two-dimensional gel electrophoresis, we have examined the proteins phosphorylated in several CSF-dependent murine lymphoid and myeloid cell lines following stimulation with the appropriate growth factor or a direct activator of PK-C, a synthetic analogue of diacyglycerol (OAG). We found that stimulation with OAG induced rapid phosphorylation of a 68 X 103M r protein (p68) in each of the four cell lines tested and the same protein was also phosphorylated in response to growth factors (Evans et al. 1987 ). There was, however, an intriguing exception to the general finding that p68 phosphorylation was induced in all cells responding to an appropriate growth factor. One of the cell lines (N SF 60.8) can proliferate in response to either G M -CSF or G -C SF but p68 phosphorylation was induced only by G -C SF. This finding suggests the existence of an alternative pathway, involving protein phosphorylation, that leads to cell growth. Phosphorylation of p68 in two CSF-dependent clones is shown in Fig. 1 . The NSF-60 cell line grows in response to G -C SF and IL-3 (multi-CSF). p68 was phosphorylated by both growth factors but not by G M -CSF or IL-2, which do not stimulate growth. The N S F 60.8 cell line responds to all three C SF s for proliferation and phosphorylation of p68. While p68 is the predominant protein phosphorylated in these cells in response to phorbol esters its biochemical function is still unknown. In addition to p68 a protein of M r 30X103 was also phosphorylated in response to IL-2 or OAG in IL-2-dependent T cells, while phosphorylation of p60 and p80 was stimulated only by IL-2 (Evans & Farrar, 1987) .
More recently Ishii and coworkers (1988) have described the IL-2-dependent phosphorylation of proteins of 67 and 63x 103M t in human T-lymphocytes, that may be the human homologues of the murine proteins, p68 and p60, described above. Due to the different techniques used for the first-dimension separation (pH 3-5-10 non-equilibrating pH grandient gel electrophoresis used by us, versus pH 5-8 isoelectric focusing), it is uncertain how similar in charge these proteins are.
Whetton and coworkers (1986) showed activation of the hexose transport protein in the IL-3-dependent cell line, FD C-P1, both in vitro and in situ in response to TPA or IL-3. More recently they reported that TPA and a calcium ionophore can replace the maintenance requirement for IL-3 in these cells. They suggest that the increased glucose transport, perhaps resulting from phosphorylation of the transport protein in response to TPA/ionophore or IL-3, is important to both the survival and proliferation of FDC-P1 cells. Additionally, IL-3 has been shown to stimulate the Phosphorylation of p6 8 in NSF 60 and NSF 60.8 Myeloid Cell Lines NSF 60 NSF 60.8 Cells were washed free of conditioned medium and resuspended in phosphate/serum-free RPM 1-1640. 300 /¿Ci 0-32PC>2 was added and cells were stimulated with 1000 units/107 cells of each C S F for 10 min (Evans et al. 1987) . M ulti-CSF = IL-3. Shown in N E P H E x S D S -P A G E of phosphoproteins in the location proximal to p68.
phosphorylation of a 33 X 103 M r protein in several murine myeloid cell lines and the p33 was found to be constitutively phosphorylated in autonomous malignant clones (Garland, 1988) . The p33 protein is localized in the endoplasmic reticulum and is phosphorylated on serine residues (J. Garland, personal communication).
Since the discovery in 1980 that the transforming gene product of the Rous sarcoma virus was a tyrosine kinase (Collett et al. 1980 ) a variety of viral oncogenes and their cellular counterparts, the proto-oncogenes, have been demonstrated to possess tyrosine kinase activity (Kolata, 1983; Hunter, 1984; Hunter & Cooper, . The members of this family of proto-oncogenes are transmembrane proteins consisting of, at a minimum, an external receptor portion, a transmembrane section, and a cytoplasmic catalytic site. Included within this group are the epidermal growth factor (E G F) receptor, platelet-derived growth factor (PD G F) receptor, the insulin receptor, and the insulin-like growth factor (IG F-1) receptor (Hunter & Cooper, 1985) . Other growth factor receptors may also possess tyrosine kinase activity, but it is clear from inspection of Table 1 that all of the currently identified receptors with kinase activity are fairly large proteins. With the exception of CSF-1, the receptor of which contains intrinsic kinase activity homologous to v-fms (Sherr et al. 1985) , no other C SF receptor with tyrosine kinase activity has been formally demonstrated. Using anti-phosphotyrosine rabbit anti-serum coupled to Sepharose beads we have used affinity-capture to address whether IL-3 can stimulate tyrosine phos phorylation of cellular proteins. We found that IL-3 rapidly stimulates tyrosine kinase activity in the FDC-P1 cell line, causing elevated phosphorylation of several substrates including p213, pl41, p i 18, p81, p39, p37 and p35. Fig. 2 shows the amino acid hydrolysis patterns of phosphoproteins extracted from single-dimension PAGE of immunoaffinity purified cellular extracts.
Seven of the analysed proteins, p213, p!41, p i 18, p81, p38, p37 and p35, contained some phosphotyrosine, but with the exception of p213 all of them also contained significant amounts of phosphoserine. Surprisingly, in no case did the ratio of phosphotyrosine to phosphoserine in a protein change after IL-3 stimulation. The relative contents of phosphotyrosine and phosphoserine for the 11 proteins analysed, are presented in Table 2 . Since the ratio of phosphoserine to phosphotyro sine in a given protein did not change following increased phosphorylation, we conclude that IL-3 must induce rapid coactivation of both serine and tyrosine kinases. It is also clear that a variety of protein substrates are utilized in common by both types of phosphotransferase systems.
The presence of phosphoproteins containing only phosphoserine in the affinity pp213  99  1  ppl41  40  60  ppl 18  90  10  PP93  0  100  pp81  30  70  pp64  0  100  pp58  0  100  PP39  70  30  pp37  40  60  pp35  40  60  PP29 0 100 * Percentages were determined using a 2-dimensional scanning laser densitometer (L K B Ultrascan X L ) and 2-dimensional analysis software (LK B 2400 GelScan IX) on a lab computer (AT&T PC6300). purified extracts (p93, p64, pS8 and p29) probably indicates that these proteins are associated with other proteins which do contain phosphotyrosine. Therefore, the apparent increases in phosphorylation of the phosphoserine proteins could also represent an increased association that is regulated by the phosphorylation state of a phosphotyrosine-containing protein.
Recently Koyasu and his coworkers (1987) reported on the IL-3 stimulated tyrosine and serine phosphorylation of a membrane glycoprotein of 150000 M x (pl50). The ratio of phosphoserine to phosphotyrosine (6:4) reported for pl50 is identical to the ratio we found for a protein of similar molecular weight, pl41. Interestingly, pl50 was only phosphorylated in response to IL-3 although the cells could proliferate in response to IL-3, IL-4 or G M -CSF. Since the size of pl50 is incompatible with the suspected size of the IL-3 receptor as determined by cross linking (60-75X 103Air) they propose that pl50 may be a tyrosine kinase distinct from, but associated with the IL-3 receptor, or that the IL-3 receptor itself may be a tyrosine kinase that phosphorylates pl50 upon IL-3 binding. A third alternative mentioned is that p i50 is phosphorylated by a tyrosine kinase that is regulated by the IL-3 receptor. Koyasu et al. (1987) conclude that the tyrosine phosphorylation of pl50, which peaks at 3 min, is one of the earliest events specifically associated with IL-3 binding. While this conclusion may be correct, it also ignores the fact that there was apparently equally rapid serine phosphorylation of pl50, thus leaving open the question of which phosphotransferase system is initially activated. This is not a trivial point because it is possible that these separate kinase systems are themselves regulated by phosphorylation.
Previously we speculated that the stimulated serine/threonine phosphorylation of a 68x103M r protein by IL-3, IL-2, G -C SF or direct pharmacological activators of protein kinase C indicated that p68 represented a point of convergence for various growth factor signalling pathways and that activation of serine/threonine phos phorylation was an essential element in IL-2, IL-3 and G-CSF-mediated signal transduction. It is now clear that in addition to inducing serine/threonine phos phorylation, IL-3 also stimulates rapid phosphorylation of tyrosine in multiple proteins most of which are also phosphorylated on serine. Thus, it appears that coactivation of serine/threonine and tyrosine kinase activities plays a significant role in the biological regulation of myeloid cells by IL-3.
C S F regulation of gene expression
The intracellular effects of growth factors on their target cells have been extensively studied in different tissues such as fibroblastic cell lines induced to proliferate by serum or purified serum growth factors (epidermal growth factor (E G F ); fibroblast growth factor (F G F ); insulin, etc.) or else T cell lines induced to proliferate by IL-2 (Cleveland et al. 1987) . At the nuclear level, growth factors rapidly induce major changes in the transcriptional programme of the cell. In particular, they induce the expression of the nuclear proto-oncogenes c-jfos (Kruijer et al. 1984 ) and c-myc (Greenberg & Ziff, 1983; Muller et al. 1984 ) the cellular genomic counterparts of retroviral transforming genes (Cleveland et al. 1987; Bishop, 1985) . These proto oncogene protein products, being located in the nucleus, are believed to be, at least, part of the genetic elements involved in cell proliferation.
We have investigated the effect of growth factors on induction of nuclear proto oncogenes in two growth factor-dependent mouse myeloid cell lines, one of which is induced to proliferate by each of the three biochemically unique C S F s: G -CSF, G M -CSF and IL-3.
In order to investigate the effects of C SF s on proto-oncogene mRNA induction, NSF-60.8 or FDC-P1 cells were arrested in G j phase of the cell cycle by deprivation of growth factors and reduced serum concentration for the appropriate periods of time, distinct for each cell line and then allowed to proceed into the cycle by addition of lOOngml-1 of r-mu-GM-CSF (NSF-60.8 cells ) or (lOngm l-1) r-mu-IL-3 (=M ulti-C SF) (FDC-P1 cells). At indicated time points, total RNA (or poly(A) + RNA, as indicated) was extracted from the cells and submitted to Northern analysis. For both cell lines, growth factors induced c-fos mRNA expression, visualized as a 2-3 kb hybridizing species. This induction occurred rapidly, after 30min of treatment with growth factor, and was transient, the steady state level of c-fos returning to background after lh (Fig. 3A) . c-myc mRNA was also induced by growth factors in both cell lines, although with different kinetics. The maximum level of induction was reached only after 2-4 h of contact with growth factor (Fig. 3A,B) , and the level of c-myc mRNA did not return to background level even by 20h post C S F treatment (data not shown), c-myb mRNA level was high even in quiescent cells, when the level of c-myc or c-fos mRNA was minimal. It has to be noted that in NSF-60.8 cells, a genomic insertion has brought c-myb under the con trol of a retroviral promoter, which results in the transcription of a truncated c-myb message (kb instead of 3-6kb). In those cells, the level of c-myb mRNA does not seem to be regulated throughout the cell cycle (Fig. 3B) . However, in FDC-P1 cells, in which no genomic alteration of c-myb has been described, c-myb mRNA level was also high in quiescent cells, decreased rapidly, and increased again after 1 h of treat ment with growth factor. The results seen with G M -CSF on NSF-60.8 cells were also observed when G -C SF was used as the stimulant (Harel-Bellan & Farrar, 1987) .
Our results indicate that the three growth factors increased steady state levels of c-fos and c-myc on resting cells with the same kinetics. The induction of c-myc and c-fos seem therefore to occur in common with activation by a variety of growth factors in the different cell types studied so far, such as fibroblasts or lymphoid cells. This observation can now be extended to CSF-dependent myeloid cell lines, as shown for three different C SFs, IL-3, G -C SF or G M -CSF (Harel-Bellan & Farrar, 1987) . It has to be noted that the level of induction of c-fos by C S F in myeloid cell lines is quantitatively less than what is observed in fibroblasts for example, the induction of c-fos being relatively low in meyloid cells so that its relevance to the proliferative process may be questionable.
In addition to C SF regulation of proto-oncogenes we have recently examined the effects of IL-3, G -C SF, G M -CSF on myeloid cell expression of ODC steady state mRNA synthesis and stimulation of heat shock protein synthesis (Farrar et al. 1988a; Ferris et al. unpublished) . All the C SF s tested were capable of regulating T he heat shock proteins are a family of genes more ancient than proto-oncogenes, found in all phyla in the plant and animal kingdoms (Subjeck & Shyy, 1986) . We recently have shown that one member of the family, HSP 70, is modulated by IL-2 during lymphocyte growth (Ferris et al. 1988) . We extended these observations to the study of myeloid growth factors and found that IL-3, G M -CSF and G -C SF could increase levels of two distinct gene products, HSP 90 and HSP 70, by transcriptional and post-transcriptional mechanisms (Farrar et al. 1988a) . Although the function of heat shock proteins is unknown, they have been found in association with steroid receptors and pp60src and p53 oncogenes (Subjeck & Shyy, 1986) . The finding that lymphoid and haemopoietic growth factors modulate their expression lends importance to their role in cell proliferation and further suggests that mechanism(s) involved in cellular proliferation have evolved from primitive stress adaptation responses observed in eubacteria.
Molecular effects of anti-growth signals
We have used the information deduced from CSF-directed gene modulation to study the molecular effects of potent anti-growth signals to myeloid and lymphoid cells dependent upon growth factors. The two anti-growth signals chosen were cyclic AMP and gamma interferon (IFN-gamma) (Farrar et al. 1988a; Harel-Bellan & Farrar, 1988; Farrar et al. 1987; Harel-Bellan et al. 1988 ). Both cyclic AMP and IFN-gamma inhibit NSF-60.8 cell line proliferation.
We investigated the effect of 8-Br-cyclic adenosine 3': 5'monophosphate (cyclic AMP), a pharmacological activator of cyclic AMP-dependent protein kinase, on the proliferation and the nuclear proto-oncogene induction in a murine granulocyte/ macrophage colony stimulating factor-dependent myeloid cell line. Cells were growth-arrested by granulocyte macrophage colony stimulating factor and serum deprivation and allowed to proceed in the cell cycle by addition of the lymphokine in the presence or absence of 8-Br-cyclic AMP.
[3H]thymidine incorporation assays showed that addition of 8-Br-cyclic AMP inhibited the entry of cells into S phase and the subsequent proliferation. Northern analysis showed that 8-Br-cyclic AMP had opposite effects on c-fos and c-myc mRNA induction. 8-Br-cyclic AMP induced c-fos in the absence of any C SF. In the presence of C SF, c-fos mRNA was superinduced (30-fold induction compared to 4-to 5-fold by each signal alone). On the contrary, 8-Br-cyclic AMP was not able to induce c-myc in the absence of growth factor and hardly interfered with the induction of c-myc by C SF. As phorbol myristate acetate (PMA), a pharmacological activator of the lipid and Ca2+-dependent protein kinase C, is known to induce nuclear proto-oncogene mRNA in CSF-dependent cell lines, we investigated the effect of 8-Br-cyclic AMP on PMA-induced c-fos and c-myc mRNA levels. When both cyclic AMP-dependent and lipid-dependent kinase systems were co-stimulated, in the absence of C SF, c-fos message was again, superinduced (60-fold induction). On the contrary, c-myc message induction by PMA was inhibited by 80 % by coactivation of cyclic AMP-dependent protein kinase with 8-Br-cyclic AMP (Harel-Ballan & Farrar, 1988) .
When we tested the effects of 8-Br-cyclic AMP on ODC mRNA synthesis we found the cyclic AMP analogue inhibited ODC mRNA steady state accumulation (Farrar et al. 1988a; Harel-Bellan et al. 1988) . G M -C SF stimulated O D C m RN A and enzyme levels were markedly reduced as early as 2 h after-treatment (Farrar et al. 1988a (Fig. 4) . The effect was observed as early as 30 min after induction and the inhibition was complete after 20 h. Gamma interferon did not impair the transcriptional activation of c-myc gene, and had only a slight destabilizing effect on the mature c-myc message. Study of the processing steps of c-myc m RNA precursor indicated that in the presence of gamma interferon, a putative 3-6kb splice intermediately accumulated instead of the mature message, suggesting that gamma interferon inhibits the splicing of c-myc precursor (Harel-Bellan et al. 1988) .
The characterization of molecular events regulated by proliferative C S F s not only aid in our understanding of the mechanism(s) controlling the growth and differen tiation of haemopoietic progenitors, but also serve operationally to examine the effects of potent anti-signals to the biological systems stimulated by growth factors. F a r r a r , W. L ., B e l l a n -H a r e l , A., C l e v e l a n d G a r l a n d , J. M. (1988) . Rapid phosphorylation of a specific 33-kDa protein (p33) associated with growth stimulated by murine and rat IL 3 in different IL 3-dependent cell lines, and its constitutive expression in a malignant independent clone. Leukemia 2, 94-102. H a r e l -B e l l a n , A. & F a r r a r , W. L . (1988) . Regulation of proliferation in a murine C SF-
